All Stories

  1. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?

    Article • Journal of Consulting and Clinical Psychology, July 2021, American Psychological Association (APA)

    David Coghill

  2. Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD

    Article • Journal of Attention Disorders, August 2017, SAGE Publications

    David Coghill

  3. BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents

    Article • Journal of Psychopharmacology, April 2016, SAGE Publications

    David Coghill

  4. Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database

    Article • CNS Drugs, April 2016, Springer Science + Business Media

    David Coghill

  5. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study

    Article • BMJ Open, April 2016, BMJ

    David Coghill

  6. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway

    Article • Child and Adolescent Psychiatry and Mental Health, November 2015, Springer Science + Business Media

    David Coghill

  7. Towards an ICF core set for ADHD: a worldwide expert survey on ability and disability

    Article • European Child & Adolescent Psychiatry, October 2015, Springer Science + Business Media

    Professor Sunil Karande, David Coghill

  8. Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities

    Article • Asia-Pacific Psychiatry, September 2015, Wiley

    David Coghill

  9. Editorial: Painting by numbers: using modern approaches to analyse and visualise clinical and research data

    Article • Journal of Child Psychology and Psychiatry, September 2015, Wiley

    David Coghill

  10. Group cognitive-behavioural therapy may reduce symptoms and impairment in adolescents with attention-deficit/hyperactivity disorder

    Article • Evidence-Based Mental Health, September 2015, BMJ

    David Coghill

  11. Are NICE guidelines losing their impartiality?

    Article • The British Journal of Psychiatry, September 2015, Royal College of Psychiatrists

    David Coghill

  12. Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

    Article • BMC Psychiatry, August 2015, Springer Science + Business Media

    David Coghill

  13. Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes

    Article • Expert Review of Clinical Pharmacology, June 2015, Taylor & Francis

    David Coghill

  14. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls

    Article • European Child & Adolescent Psychiatry, June 2015, Springer Science + Business Media

    David Coghill

  15. A comprehensive scoping review of ability and disability in ADHD using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY)

    Article • European Child & Adolescent Psychiatry, June 2015, Springer Science + Business Media

    Professor Sunil Karande, David Coghill

  16. Services for adults with ADHD: work in progress

    Article • BJPsych Bulletin, June 2015, Royal College of Psychiatrists

    David Coghill

  17. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate

    Article • European Child & Adolescent Psychiatry, May 2015, Springer Science + Business Media

    David Coghill

  18. Ability and Disability in Autism Spectrum Disorder: A Systematic Literature Review Employing the International Classification of Functioning, Disability and Health‐Children and Youth Version

    Article • Autism Research, March 2015, Wiley

    Professor Sunil Karande, David Coghill

  19. Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, March 2015, Elsevier

    David Coghill

  20. Commentary: We've only just begun: unravelling the underlying genetics of neurodevelopmental disorders - a commentary on Kiser et al. (2015)

    Article • Journal of Child Psychology and Psychiatry, February 2015, Wiley

    Professor David Coghill, David Coghill

  21. The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research

    Article • CNS Drugs, February 2015, Springer Science + Business Media

    David Coghill

  22. Methylphenidate and the Risk of Trauma

    Article • PEDIATRICS, December 2014, American Academy of Pediatrics (AAP)

    Dr Wilfred Hing Sang Wong, David Coghill

  23. The use of stimulant medications for non-core aspects of ADHD and in other disorders

    Article • Neuropharmacology, December 2014, Elsevier

    Professor David Coghill, David Coghill

  24. The foundations of next generation attention-deficit/hyperactivity disorder neuropsychology: building on progress during the last 30 years

    Article • Journal of Child Psychology and Psychiatry, November 2014, Wiley

    Professor David Coghill, David Coghill

  25. Editorial Perspective: Laying the foundations for next generation models of ADHD neuropsychology

    Article • Journal of Child Psychology and Psychiatry, October 2014, Wiley

    Professor David Coghill, David Coghill

  26. Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial

    Article • October 2014, Taylor & Francis

    Professor David Coghill, David Coghill

  27. Effects of Methylphenidate on Cognitive Functions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Evidence from a Systematic Review and a Meta-Analysis

    Article • Biological Psychiatry, October 2014, Elsevier

    David Coghill

  28. Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study

    Article • Journal of Psychopharmacology, September 2014, SAGE Publications

    David Coghill

  29. Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

    Article • CNS Drugs, August 2014, Springer Science + Business Media

    David Coghill

  30. Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

    Article • CNS Drugs, July 2014, Springer Science + Business Media

    David Coghill

  31. Editorial: Acknowledging complexity and heterogeneity in causality - implications of recent insights into neuropsychology of childhood disorders for clinical practice

    Article • Journal of Child Psychology and Psychiatry, June 2014, Wiley

    Professor David Coghill, David Coghill

  32. Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, June 2014, Elsevier

    David Coghill

  33. Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification

    Article • Human Brain Mapping, May 2014, Wiley

    David Coghill

  34. A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

    Article • CNS Drugs, May 2014, Springer Science + Business Media

    Professor David Coghill, David Coghill

  35. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

    Article • Journal of Psychopharmacology, February 2014, SAGE Publications

    David Coghill

  36. Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD

    Article • Trials, January 2014, Springer Science + Business Media

    David Coghill

  37. Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

    Article • European Child & Adolescent Psychiatry, December 2013, Springer Science + Business Media

    David Coghill

  38. Prevalence and contributing factors to attention deficit hyperactivity disorder: A study of five- to fifteen-year-old children in Zhabei District, Shanghai

    Article • Asia-Pacific Psychiatry, December 2013, Wiley

    David Coghill

  39. Brain imaging: closing the gap between basic research and clinical application is urgently needed

    Article • European Child & Adolescent Psychiatry, December 2013, Springer Science + Business Media

    Professor David Coghill, David Coghill

  40. A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models

    Article • Psychological Medicine, October 2013, Cambridge University Press

    Professor David Coghill, David Coghill

  41. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    David Coghill

  42. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

    Article • BMC Psychiatry, September 2013, Springer Science + Business Media

    David Coghill

  43. Editorial: Do clinical services need to take conduct disorder more seriously?

    Article • Journal of Child Psychology and Psychiatry, August 2013, Wiley

    Professor David Coghill, David Coghill

  44. Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

    Article • CNS Drugs, August 2013, Springer Science + Business Media

    David Coghill

  45. Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder

    Article • CNS Drugs, July 2013, Springer Science + Business Media

    David Coghill

  46. A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): improvements in executive functioning do not explain clinical improvement

    Article • Psychological Medicine, July 2013, Cambridge University Press

    Professor David Coghill, David Coghill

  47. A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and Adolescents

    Article • CNS Drugs, June 2013, Springer Science + Business Media

    David Coghill

  48. Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial

    Article • European Child & Adolescent Psychiatry, May 2013, Springer Science + Business Media

    David Coghill

  49. An inventory of European data sources for the long-term safety evaluation of methylphenidate

    Article • European Child & Adolescent Psychiatry, March 2013, Springer Science + Business Media

    David Coghill

  50. Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments

    Article • American Journal of Psychiatry, March 2013, American Psychiatric Association

    David Coghill

  51. Occupational issues of adults with ADHD

    Article • BMC Psychiatry, February 2013, Springer Science + Business Media

    David Coghill

  52. Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

    Article • Journal of Child Psychology and Psychiatry, January 2013, Wiley

    David Coghill

  53. The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)

    Article • Child and Adolescent Psychiatry and Mental Health, January 2013, Springer Science + Business Media

    David Coghill

  54. Predictive classification of individual magnetic resonance imaging scans from children and adolescents

    Article • European Child & Adolescent Psychiatry, August 2012, Springer Science + Business Media

    David Coghill

  55. Editorial: Getting the basics right in mental health assessments of children and young people

    Article • Journal of Child Psychology and Psychiatry, July 2012, Wiley

    Professor David Coghill, David Coghill

  56. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

    Article • European Child & Adolescent Psychiatry, July 2012, Springer Science + Business Media

    Professor David Coghill, David Coghill

  57. Annual Research Review: Categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders - implications of recent empirical study

    Article • Journal of Child Psychology and Psychiatry, January 2012, Wiley

    David Coghill

  58. Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD

    Article • BMC Psychiatry, November 2011, Springer Science + Business Media

    Professor David Coghill, David Coghill

  59. What does it mean? Looking beyond group differences in clinical research

    Article • European Child & Adolescent Psychiatry, October 2011, Springer Science + Business Media

    Professor David Coghill, David Coghill

  60. Editorial: Focusing on a moving target: key themes for research and practice in adolescent mental health

    Article • Journal of Child Psychology and Psychiatry, September 2011, Wiley

    Professor David Coghill, David Coghill

  61. Pragmatic measures in paediatric psychopharmacology — Are we getting it right?

    Article • European Neuropsychopharmacology, August 2011, Elsevier

    Professor David Coghill, David Coghill

  62. A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder

    Article • Journal of Child Psychology and Psychiatry, July 2011, Wiley

    David Coghill

  63. Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee

    Article • European Child & Adolescent Psychiatry, November 2010, Springer Science + Business Media

    David Coghill

  64. European guidelines on managing adverse effects of medication for ADHD

    Article • European Child & Adolescent Psychiatry, November 2010, Springer Science + Business Media

    David Coghill

  65. The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder

    Article • CNS Drugs, October 2010, Springer Science + Business Media

    Professor David Coghill, David Coghill

  66. Adolescents in need: recognizing the broad impact of mental health problems in adolescents

    Article • European Child & Adolescent Psychiatry, September 2010, Springer Science + Business Media

    Professor David Coghill, David Coghill

  67. Attention-deficit/hyperactivity disorder and Williams syndrome: Shared behavioral and neuropsychological profiles

    Article • Journal of Clinical and Experimental Neuropsychology, August 2010, Taylor & Francis

    David Coghill

  68. Stimulant Drug Effects on Attention Deficit/Hyperactivity Disorder: A Review of the Effects of Age and Sex of Patients

    Article • Current Pharmaceutical Design, July 2010, Bentham Science Publishers

    Professor David Coghill, David Coghill

  69. Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations

    Article • European Child & Adolescent Psychiatry, June 2010, Springer Science + Business Media

    David Coghill

  70. Editorial: taking our time - a long-term perspective on child and adolescent mental health provides invaluable insights for scientists, clinicians and policy makers

    Article • Journal of Child Psychology and Psychiatry, April 2010, Wiley

    Professor David Coghill, David Coghill

  71. Molecular genetics of attention-deficit/hyperactivity disorder: an overview

    Article • European Child & Adolescent Psychiatry, February 2010, Springer Science + Business Media

    Professor David Coghill, David Coghill

  72. Neurofeedback training improves ADHD symptoms more than attention skills training

    Article • Evidence-Based Mental Health, February 2010, BMJ

    David Coghill

  73. Adverse Reactions to Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder: Structure and Associations with Clinical Characteristics and Symptom Control

    Article • Journal of Child and Adolescent Psychopharmacology, December 2009, Mary Ann Liebert Inc

    David Coghill

  74. Measuring Methylphenidate Response in Attention-Deficit/Hyperactvity Disorder: How Are Laboratory Classroom-Based Measures Related to Parent Ratings?

    Article • Journal of Child and Adolescent Psychopharmacology, December 2009, Mary Ann Liebert Inc

    David Coghill

  75. The MTA at 8

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 2009, Elsevier

    David Coghill

  76. The genetics of attention-deficit/hyperactivity disorder

    Article • Expert Review of Neurotherapeutics, October 2009, Taylor & Francis

    Professor David Coghill, David Coghill

  77. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation

    Article • Health Technology Assessment, October 2009, National Institute for Health Research

    David Coghill, Dr Yen-Fu Chen

  78. Short-Term Effectiveness of Medication and Psychosocial Intervention in a Cohort of Newly Diagnosed Patients With Inattention, Impulsivity, and Hyperactivity Problems

    Article • Journal of Attention Disorders, September 2009, SAGE Publications

    David Coghill

  79. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder

    Article • Neuroscience Letters, September 2009, Elsevier

    David Coghill

  80. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

    Article • European Child & Adolescent Psychiatry, July 2009, Springer Science + Business Media

    David Coghill

  81. Practitioner Review: Quality of life in child mental health - conceptual challenges and practical choices

    Article • Journal of Child Psychology and Psychiatry, May 2009, Wiley

    Professor David Coghill, David Coghill

  82. Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology

    Article • Journal of Psychopharmacology, March 2009, SAGE Publications

    Anita Thapar, David Coghill

  83. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

    Article • The British Journal of Psychiatry, March 2009, Royal College of Psychiatrists

    David Coghill

  84. Neuropsychological functioning in depressed adolescent girls

    Article • Journal of Affective Disorders, November 2008, Elsevier

    Professor David Coghill, David Coghill

  85. Gemeinsame Stellungnahme der Leitliniengruppe des European Network for Hyperkinetic Disorders (EUNETHYDIS) und des deutschen zentralen adhs-netzes zur EKG- Ableitung bei Verschreibung von Methylphenidat

    Article • Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, November 2008, Hogrefe Publishing Group

    David Coghill

  86. Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

    Article • Child and Adolescent Psychiatry and Mental Health, October 2008, Springer Science + Business Media

    David Coghill

  87. The Provision and Nature of ADHD Services for Children/Adolescents in the UK: Results from a Nationwide Survey

    Article • Clinical Child Psychology and Psychiatry, April 2008, SAGE Publications

    David Coghill

  88. Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen 1bearbeitete deutsche Version von Banaschewski et al., Long-acting medications for the hyperkinetic disorders; Eur Child Adolesc Psychiatry (2006); mit freundlicher Genehmigung des ...

    Article • Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, March 2008, Hogrefe Publishing Group

    David Coghill

  89. Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen 1bearbeitete deutsche Version von Banaschewski et al., Long-acting medications for the hyperkinetic disorders; Eur Child Adolesc Psychiatry (2006); mit freundlicher Genehmigung des ...

    Article • Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, March 2008, Hogrefe Publishing Group

    David Coghill

  90. Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

    Article • PEDIATRICS, January 2008, American Academy of Pediatrics (AAP)

    David Coghill

  91. Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder

    Article • CNS Drugs, January 2008, Springer Science + Business Media

    Professor David Coghill, David Coghill

  92. The validity, reliability and normative scores of the parent, teacher and self report versions of the Strengths and Difficulties Questionnaire in China

    Article • Child and Adolescent Psychiatry and Mental Health, January 2008, Springer Science + Business Media

    David Coghill

  93. Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder

    Article • European Child & Adolescent Psychiatry, December 2007, Springer Science + Business Media

    David Coghill

  94. The Neuropsychological Effects of Chronic Methylphenidate on Drug-Naive Boys with Attention-Deficit/Hyperactivity Disorder

    Article • Biological Psychiatry, November 2007, Elsevier

    Professor David Coghill, David Coghill

  95. Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes

    Article • Evidence-Based Mental Health, November 2007, BMJ

    David Coghill

  96. Sex Differences in the Response of Children With ADHD to Once-Daily Formulations of Methylphenidate

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, June 2007, Elsevier

    David Coghill

  97. Co-existing psychiatric problems in ADHD in the ADORE cohort

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  98. Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  99. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder

    Article • Archives of Clinical Neuropsychology, December 2006, Oxford University Press (OUP)

    David Coghill

  100. Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  101. Influence of gender on Attention-Deficit/Hyperactivity Disorder in Europe – ADORE

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  102. Naturalistic-observational studies in the framework of ADHD health care

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  103. Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  104. Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  105. The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  106. Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  107. Which factors impact on clinician-rated impairment in children with ADHD?

    Article • European Child & Adolescent Psychiatry, December 2006, Springer Science + Business Media

    David Coghill

  108. Osmotic, controlled-release methylphenidate for the treatment of ADHD

    Article • Expert Opinion on Pharmacotherapy, October 2006, Informa Healthcare

    Professor David Coghill, David Coghill

  109. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II - broader executive and non-executive domains

    Article • Journal of Child Psychology and Psychiatry, June 2006, Wiley

    David Coghill

  110. Long-acting medications for the hyperkinetic disorders

    Article • European Child & Adolescent Psychiatry, May 2006, Springer Science + Business Media

    David Coghill

  111. Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder

    Article • Psychological Medicine, April 2005, Cambridge University Press

    Professor David Coghill, David Coghill

  112. Whither causal models in the neuroscience of ADHD?

    Article • Developmental Science, March 2005, Wiley

    David Coghill

  113. Use of stimulants for attention deficit hyperactivity disorder: FOR

    Article • BMJ, October 2004, BMJ

    David Coghill

  114. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data

    Article • BMC Psychiatry, September 2004, Springer Science + Business Media

    David Coghill

  115. Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder

    Article • Psychopharmacology, May 2004, Springer Science + Business Media

    Professor David Coghill, David Coghill

  116. Evaluation of a direct immunofluorescence test for diagnosing gonorrhoea.

    Article • Journal of Clinical Pathology, October 1985, BMJ

    David Coghill